Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2011 1
2012 2
2019 1
2020 4
2021 7
2022 5
2023 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Vortioxetine Improves Depressive Symptoms and Cognition in Parkinson's Disease Patients with Major Depression: An Open-Label Prospective Study.
Santos García D, Alonso Losada MG, Cimas Hernando I, Cabo López I, Yáñez Baña R, Alonso Redondo R, Paz González JM, Cores Bartolomé C, Feal Painceiras MJ, Íñiguez Alvarado MC, Labandeira C, García Díaz I. Santos García D, et al. Among authors: paz gonzalez jm. Brain Sci. 2022 Oct 29;12(11):1466. doi: 10.3390/brainsci12111466. Brain Sci. 2022. PMID: 36358393 Free PMC article.
Safinamide improves sleep and daytime sleepiness in Parkinson's disease: results from the SAFINONMOTOR study.
Santos García D, Cabo López I, Labandeira Guerra C, Yáñez Baña R, Cimas Hernando MI, Paz González JM, Alonso Losada MG, Gonzalez Palmás MJ, Cores Bartolomé C, Martínez Miró C. Santos García D, et al. Among authors: paz gonzalez jm. Neurol Sci. 2022 Apr;43(4):2537-2544. doi: 10.1007/s10072-021-05607-2. Epub 2021 Sep 23. Neurol Sci. 2022. PMID: 34554335 Free PMC article.
Predictors of clinically significant quality of life impairment in Parkinson's disease.
Santos García D, de Deus Fonticoba T, Cores C, Muñoz G, Paz González JM, Martínez Miró C, Suárez E, Jesús S, Aguilar M, Pastor P, Planellas L, Cosgaya M, García Caldentey J, Caballol N, Legarda I, Hernández Vara J, Cabo I, López Manzanares L, González Aramburu I, Ávila Rivera MA, Catalán MJ, Nogueira V, Puente V, Ruíz de Arcos M, Borrué C, Solano Vila B, Álvarez Sauco M, Vela L, Escalante S, Cubo E, Carrillo Padilla F, Martínez Castrillo JC, Sánchez Alonso P, Alonso Losada MG, López Ariztegui N, Gastón I, Clavero P, Kulisevsky J, Blázquez Estrada M, Seijo M, Rúiz Martínez J, Valero C, Kurtis M, de Fábregues O, González Ardura J, Ordás C, López Díaz LM, McAfee D, Martinez-Martin P, Mir P; COPPADIS Study Group. Santos García D, et al. Among authors: paz gonzalez jm. NPJ Parkinsons Dis. 2021 Dec 16;7(1):118. doi: 10.1038/s41531-021-00256-w. NPJ Parkinsons Dis. 2021. PMID: 34916528 Free PMC article.
Risk of Cognitive Impairment in Patients With Parkinson's Disease With Visual Hallucinations and Subjective Cognitive Complaints.
Santos-García D, de Deus Fonticoba T, Cores Bartolomé C, Feal Painceiras MJ, Paz González JM, Martínez Miró C, Jesús S, Aguilar M, Pastor P, Planellas L, Cosgaya M, García Caldentey J, Caballol N, Legarda I, Hernández Vara J, Cabo I, López Manzanares L, González Aramburu I, Ávila Rivera MA, Gómez Mayordomo V, Nogueira V, Puente V, Dotor García-Soto J, Borrué C, Solano Vila B, Álvarez Sauco M, Vela L, Escalante S, Cubo E, Carrillo Padilla F, Martínez Castrillo JC, Sánchez Alonso P, Alonso Losada MG, López Ariztegui N, Gastón I, Kulisevsky J, Blázquez Estrada M, Seijo M, Rúiz Martínez J, Valero C, Kurtis M, de Fábregues O, González Ardura J, Alonso Redondo R, Ordás C, López Díaz L LM, McAfee D, Martinez-Martin P, Mir P; COPPADIS Study Group. Santos-García D, et al. Among authors: paz gonzalez jm. J Clin Neurol. 2023 Jul;19(4):344-357. doi: 10.3988/jcn.2022.0186. Epub 2023 Jan 2. J Clin Neurol. 2023. PMID: 36647231 Free PMC article.
Isolated speech-induced lingual dystonia successfully treated with botulinum neurotoxin.
Cores-Bartolomé C, Paz-González JM, García-Antelo MJ, Santos-García D. Cores-Bartolomé C, et al. Among authors: paz gonzalez jm. Neurologia (Engl Ed). 2022 May;37(4):306-308. doi: 10.1016/j.nrl.2021.05.010. Epub 2021 Jul 31. Neurologia (Engl Ed). 2022. PMID: 34344540 Free article. English, Spanish. No abstract available.
Pain Improvement in Parkinson's Disease Patients Treated with Safinamide: Results from the SAFINONMOTOR Study.
Santos García D, Yáñez Baña R, Labandeira Guerra C, Cimas Hernando MI, Cabo López I, Paz González JM, Alonso Losada MG, Gonzalez Palmás MJ, Cores Bartolomé C, Martínez Miró C. Santos García D, et al. Among authors: paz gonzalez jm. J Pers Med. 2021 Aug 16;11(8):798. doi: 10.3390/jpm11080798. J Pers Med. 2021. PMID: 34442442 Free PMC article.
Staging Parkinson's Disease Combining Motor and Nonmotor Symptoms Correlates with Disability and Quality of Life.
Santos García D, De Deus Fonticoba T, Paz González JM, Cores Bartolomé C, Valdés Aymerich L, Muñoz Enríquez JG, Suárez E, Jesús S, Aguilar M, Pastor P, Planellas LL, Cosgaya M, García Caldentey J, Caballol N, Legarda I, Hernández Vara J, Cabo I, López Manzanares L, González Aramburu I, Ávila Rivera MA, Catalán MJ, Nogueira V, Puente V, García Moreno JM, Borrué C, Solano Vila B, Álvarez Sauco M, Vela L, Escalante S, Cubo E, Carrillo Padilla F, Martínez Castrillo JC, Sánchez Alonso P, Alonso Losada MG, López Ariztegui N, Gastón I, Kulisevsky J, Blázquez Estrada M, Seijo M, Rúiz Martínez J, Valero C, Kurtis M, de Fábregues O, González Ardura J, Ordás C, López Díaz L, Mir P, Martinez-Martin P, Coppadis Study Group. Santos García D, et al. Among authors: paz gonzalez jm. Parkinsons Dis. 2021 May 13;2021:8871549. doi: 10.1155/2021/8871549. eCollection 2021. Parkinsons Dis. 2021. PMID: 34094501 Free PMC article.
Constipation Predicts Cognitive Decline in Parkinson's Disease: Results from the COPPADIS Cohort at 2-Year Follow-up and Comparison with a Control Group.
Santos García D, García Roca L, de Deus Fonticoba T, Cores Bartolomé C, Naya Ríos L, Canfield H, Paz González JM, Martínez Miró C, Jesús S, Aguilar M, Pastor P, Planellas L, Cosgaya M, García Caldentey J, Caballol N, Legarda I, Hernández Vara J, Cabo I, López Manzanares L, González Aramburu I, Ávila Rivera MA, Gómez Mayordomo V, Nogueira V, Puente V, Dotor García-Soto J, Borrué C, Solano Vila B, Álvarez Sauco M, Vela L, Escalante S, Cubo E, Carrillo Padilla F, Martínez Castrillo JC, Sánchez Alonso P, Alonso Losada MG, López Ariztegui N, Gastón I, Kulisevsky J, Blázquez Estrada M, Seijo M, Rúiz Martínez J, Valero C, Kurtis M, de Fábregues O, González Ardura J, Alonso Redondo R, Ordás C, López Díaz L LM, McAfee D, Martinez-Martin P, Mir P; COPPADIS Study Group. Santos García D, et al. Among authors: paz gonzalez jm. J Parkinsons Dis. 2022;12(1):315-331. doi: 10.3233/JPD-212868. J Parkinsons Dis. 2022. PMID: 34602501
Effectiveness of Safinamide over Mood in Parkinson's Disease Patients: Secondary Analysis of the Open-label Study SAFINONMOTOR.
Labandeira CM, Alonso Losada MG, Yáñez Baña R, Cimas Hernando MI, Cabo López I, Paz González JM, Gonzalez Palmás MJ, Martínez Miró C, Santos García D. Labandeira CM, et al. Among authors: paz gonzalez jm. Adv Ther. 2021 Oct;38(10):5398-5411. doi: 10.1007/s12325-021-01873-w. Epub 2021 Sep 15. Adv Ther. 2021. PMID: 34523075 Free PMC article.
19 results